Results for tag: "Toujeo"

Toujeo is a long-acting insulin used to treat adults with type 1 and type 2 diabetes. It is a part of the Endocrine and Metabolic Disorders Drugs market, which includes medications used to treat a variety of conditions, such as diabetes, thyroid disorders, and obesity. Toujeo is a once-daily, long-acting insulin that helps to control blood sugar levels. It is designed to provide a steady, consistent level of insulin throughout the day, helping to reduce the risk of hypoglycemia. The Endocrine and Metabolic Disorders Drugs market is a rapidly growing sector, with a wide range of products available to treat a variety of conditions. Companies in this market include Sanofi, Novo Nordisk, Eli Lilly, Merck, and AstraZeneca. Show Less Read more